POSSIBILITIES OF COMBINED THERAPY IN REDUCING A CARDIOVASCULAR RISK

Download full text PDF
Issue: 
4
Year: 
2015

A. Ermolaeva; O. Dralova, Candidate of Medical Sciences; M. Maksimov, MD I.M. Sechenov First Moscow State Medical University

The paper gives the results of investigating the antihypertensive and hypolipidemic efficiency of combined antihypertensive therapy with the angiotensin-converting enzyme inhibitor perindopril and the thiazide-like diuretic indapamide.

Keywords: 
angiotensin-converting enzyme inhibitors
perindopril
HMG-CoA reductase inhibitor
rosuvastatin
hypertension
dyslipidemia



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Federal'naja sluzhba gosudarstvennoj statistiki (Rosstat). Demograficheskij ezhegodnik Rossii – 2013 god. Elektronnyj resurs. URL:http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/publications/catalog/doc_1137674209312
  2. Stamler J., Wentworth D., Neaton D. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension: Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial // Am J Med. – 1986; 80: 33–9.
  3. Karpov Ju.A. Lechenie bol'nyh serdechno-sosudistymi zabolevanijami: rol' blokady renin-angiotenzinovoj sistemy s pomosch'ju sartanov // Rus. med. zhurn. – 2009; 23: 1548–54.
  4. Medvedev I.N., Kumova T.A., Gamolina O.V. Rol' renin-angiotenzinal'dosteronovoj sistemy v razvitii arterial'noj gipertonii // Ros. kardi-ol. zhurn. – 2009; 4: 82–4.
  5. Ostroumova O.D., Maksimov M.L. Mesto ingibitorov angiotenzin- prevraschajuschego fermenta v lechenii arterial'noj gipertonii u razlichnyh grupp patsientov // Kardiovask. ter. i profilakt. – 2010; 9 (7): 90–6.
  6. Ferrario C., Richmond R., Smith R. et al. Renin-angiotensin system as a therapeutic target in managing atherosclerosis // Am. J. Ther. – 2004; 11 (1): 44–53.
  7. Morgado M., Rolo S., Macedo A. et al. Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice // J. Cardiovasc. Dis. Res. – 2011; 2 (1): 44–9
  8. Borghi C., Prandin G., Costa V. et al. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia // J. Cardiovasc. Pharmacol. – 2000; 35: 549–55.
  9. Borghi C., Dormi A., Veronesi M. et al. Association between different lipid lowering treatment strategies and blood pressure control in the Brisighella Heart Study // Am. Heart J. – 2004; 148: 285–92.
  10. Winocour P. Drug therapy for prevention of cardiovascular disease – should surrogate measures be abandoned? // Clin. Med. – 2005; 5: 282–7.
  11. Dagenais G., Pogue J., Fox K. et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials // Lancet. – 2006; 12, 368 (9535): 581–8.
  12. Chazova I.E., Kuharchuk V.V., Ratova L.G. i dr. Vozmozhnosti gipolipidemicheskoj terapii bol'nyh arterial'noj gipertoniej (po rezul'tatam pro-grammy ROZA – ROZuvastatin u patsientov s Arterial'noj gipertoniej) // Sistemnye gipertenzii. – 2006; 2: 23–6.